Growth Metrics

Exagen (XGN) Total Debt (2018 - 2025)

Historic Total Debt for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $22.9 million.

  • Exagen's Total Debt rose 1327.21% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year increase of 1327.21%. This contributed to the annual value of $20.2 million for FY2024, which is 384.71% up from last year.
  • As of Q3 2025, Exagen's Total Debt stood at $22.9 million, which was up 1327.21% from $23.0 million recorded in Q2 2025.
  • Exagen's 5-year Total Debt high stood at $29.3 million for Q1 2023, and its period low was $19.4 million during Q2 2023.
  • For the 5-year period, Exagen's Total Debt averaged around $24.0 million, with its median value being $23.0 million (2025).
  • Per our database at Business Quant, Exagen's Total Debt tumbled by 3342.53% in 2024 and then surged by 1344.99% in 2025.
  • Quarter analysis of 5 years shows Exagen's Total Debt stood at $27.5 million in 2021, then grew by 5.42% to $29.0 million in 2022, then crashed by 32.7% to $19.5 million in 2023, then rose by 3.85% to $20.2 million in 2024, then increased by 13.32% to $22.9 million in 2025.
  • Its Total Debt stands at $22.9 million for Q3 2025, versus $23.0 million for Q2 2025 and $20.9 million for Q1 2025.